Through its cutting-edge NGS (next-generation sequencing) platform, bioinformatics analysis and comprehensive services, ACT Genomics Hong Kong delivers precision medicine solutions based on cancer genetic variants detection informatics, and formulates personalised therapy for cancer patients to improve treatment efficacy.